4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-22-024132
President and CEO bought 17,700 shares at $3.36 ($59,546)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brady Todd C President and CEO | 2022-06-23 | Purchase | +17,700 | $3.36 | $59,546 | 1,216,535 | D |
| Open-market purchases · 17,700 sh · avg $3.36 · $59,546 | |||||||
Loading xslF345X03/doc4.xml…